Qeen Biotechnologies secures C$1 million in growth financing from Investissement Québec for UK and European expansion

Québec biotechnology company Qeen Biotechnologies has secured C$1 million in growth financing from Investissement Québec to accelerate its expansion across the United Kingdom and Europe. The expansion covers UK and European market development, GMP manufacturing and supply of phage clinical-trial materials, regulatory and import pathways for clinical trials and special-access treatments, and partnerships with healthcare systems, biotechnology companies and investors.